Markets › United States › NAS › ATRA

Atara Biotherapeutics Inc

NAS:ATRAHealthcarenasdaq_composite

$9.16+2.23%At closeAt close · Wed 21 Oct · ≈ AED 33.64 · Market cap $91.95M · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	−1,286.4%	−324.7%	−3.7%	83.7%	82.4%	—	—
Operating margin	—	−1,673.9%	−441.2%	−3,219.5%	−64.7%	29.7%	29.7%	+0.0 pts
Net margin	—	−1,672.3%	−359.1%	−3,220.9%	−66.2%	27.1%	27.1%	+0.0 pts
EBITDA margin	—	−1,626.1%	−349.6%	−3,102.7%	−58.7%	32.0%	—	—
Return on equity	−66.3%	−121.6%	−180.3%	278.3%	87.8%	−84.9%	−84.9%	+0.0 pts
Return on assets	−52.1%	−72.7%	−60.7%	−166.8%	−78.3%	161.5%	161.5%	+0.0 pts
Return on capital employed	−61.2%	−94.0%	−94.3%	−1,185.7%	327.5%	675.0%	—	—
Debt / equity	0.0×	0.1×	0.6×	−0.6×	−0.5×	−1.4×	−1.4×	+0.0%
Debt / assets	2.6%	6.0%	19.0%	35.0%	40.2%	260.9%	—	—
Interest coverage	0.0×	0.0×	−752.0×	−52.2×	−18.1×	9.5×	—	—
Current ratio	6.3×	3.6×	3.7×	0.7×	0.5×	0.8×	0.8×	+0.0%
Quick ratio	6.3×	3.6×	3.7×	0.6×	0.4×	0.8×	—	—
Cash ratio	2.4×	1.0×	1.2×	0.2×	0.2×	0.6×	0.6×	+0.0%
Asset turnover	0.0×	0.0×	0.2×	0.1×	1.2×	6.0×	—	—
Inventory turnover	—	—	170.2×	0.9×	2.0×	—	—	—
Receivables turnover	0.0×	20.6×	1.6×	0.3×	87.0×	96.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—